Popular Articles

Alarming Rise In Deadly Skin Cancer Cases, UK
There has been an alarming rise in new cases of the deadliest form of skin cancer in the UK, with binge tanning cited as a main reason, said a

Newly Identified Genes May Help Improve Treatment For Melanoma Patients, Pitt Study Finds
Researchers from the University of Pittsburgh Cancer Institute (UPCI) have identified eight genes that help predict a melanoma patient"s response to treatment. The new findings are being presented at the 45th annual meeting of the American Society of Clinical Oncology (ASCO), May 29 to June 2, in Orlando, Fla.
News of the day
2009/044 NICE Guidance Recommends Tenofovir Disoproxil For Hepatitis B
The National Institute for Health and Clinical Excellence (NICE) has today (22 July) published final guidance recommending the use of tenofovir disoproxil for the treatment of people with chronic HBeAg-positive or HBeAg-negative hepatitis B in whom antiviral treatment is indicated.
Diagnostics

The Preclinical Natural History Of Serous Ovarian Cancer: Defining The Target For Early Detection

Ovarian cancer kills approximately 15,000 women in the United States every year, and more than 140,000 women worldwide. Most deaths from ovarian cancer are caused by tumors of the serous histological type, which are rarely diagnosed before the cancer has spread. In order to better understand the early natural history and to guide rational design of an early detection strategy for these cancers, Patrick Brown and colleagues from Stanford University developed models for the growth, progression, and detection of these cancers, in order to define what properties a biomarker-based screening test would require in order to be clinically useful. Funding: This work was funded by the Canary Foundation and the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. Citation: "The Preclinical Natural History of Serous Ovarian Cancer: Defining the Target for Early Detection." Brown PO, Palmer C (2009) PLoS Med 6(7): e1000114. doi:10.1371/journal.pmed.1000114 PLoS Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):